Obalon Therapeutics, Inc. (OBLN)

[r clarke]

Exactly why I'm here.

PPS showing weakness for a couple of reasons.

One was an anonymous report of some kind of accounting issue?
I will try to research that a bit more.

Additionally, they came down in sympathy to Obera? having FDA problems with their liquid balloons.

Longer term, this should be a plus for Obalon, but will take some physician and patient education.

It's discussed on the Obalon website I think, if I find it I'll post it.